Related Experiment Video
Updated: Apr 26, 2026
04:29
Economical and Efficient Protocol for Isolating and Culturing Bone Marrow-derived Dendritic Cells from Mice
Published on: July 1, 2022
9.6K
Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow
Christian Thomas Mayer1, Peyman Ghorbani1, Amrita Nandan1
1Institute of Infection Immunology, TWINCORE, Centre for Experimental and Clinical Infection Research, Medical School Hannover and the Helmholtz Centre for Infection Research, Hannover, Germany; and.
Blood
|August 8, 2014
Summary
Researchers developed a new method to generate large numbers of CD103(+) dendritic cells (DCs) for improved T-cell immunity and tolerance. These novel iCD103-DCs mimic natural DCs and induce protective immune responses in vivo.
Area of Science:
- Immunology
- Cell Biology
- Developmental Biology
Background:
- FMS-like tyrosine kinase 3 ligand (FLT3L)-dependent dendritic cells (DCs) regulate T-cell immunity and tolerance.
- Batf3-dependent CD103(+) DCs are crucial for lymph node entry and antigen cross-presentation, making them targets for vaccines and tolerance induction.
- Current methods yield limited CD103(+) DCs, hindering research and therapeutic applications.
Purpose of the Study:
- To develop a novel method for generating substantial quantities of CD103(+) DCs (iCD103-DCs) in vitro.
- To characterize the development, function, and immune-modulating capabilities of these iCD103-DCs.
- To understand the role of granulocyte macrophage colony-stimulating factor (GM-CSF) in CD103(+) DC development.
Main Methods:
- Utilized prolonged bone marrow culture with FLT3L and GM-CSF to generate iCD103-DCs.
- Analyzed iCD103-DC development using Batf3 and Irf8 dependency.
- Assessed iCD103-DC function, including antigen cross-presentation, TLR3 response, CCR7 expression, lymph node migration, and in vivo T-cell mediated immunity.
Main Results:
- Established a novel culture method yielding large numbers of iCD103-DCs with minimal other DC subsets.
- iCD103-DCs exhibit Batf3/Irf8 dependency, express a CD8α/CD103 gene signature, and possess cross-presenting capabilities.
- iCD103-DCs mature, upregulate CCR7, migrate efficiently to lymph nodes, and induce protective T-cell immunity in vivo.
Conclusions:
- Prolonged culture with FLT3L and GM-CSF is essential for generating CD103(+) DCs.
- The novel iCD103-DC generation method provides a valuable tool for studying CD103(+) DC biology and developing immunotherapies.
- iCD103-DCs effectively induce T-cell mediated immunity, highlighting their potential in vaccination and tolerance strategies.
